ReviewInternational journal of molecular sciences2022

Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its Treatment.

Hidekatsu Yanai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.